Pregnancy Clinical Trial
Official title:
Behavioral and Environmental Factors and Time to Delivery
This study, conducted at the Naval Medical Center in San Diego, CA, will determine if having
vaginal intercourse in the last weeks of pregnancy decreases the risk of having a prolonged
pregnancy. Pregnancies that continue beyond the due date may increase health risks for the
mother and the baby. Although some believe that vaginal intercourse can help start labor in
the last weeks of pregnancy, there is not proof that it works. Some studies showed that
sexual intercourse helped and some that pregnancy lasted even longer for couples having sex.
In addition to exploring the effect of sexual intercourse on time to delivery, this study
will collect information that can be used in the future to predict when labor will naturally
start and the risk for overdue pregnancies.
Women 18 years of age and older in their first pregnancy who are carrying a single fetus with
gestational age before 38 plus 6 weeks may be eligible for this study. Candidates must be
living with their partner in a stable relationship.
Participants are asked to have sexual intercourse about three times per week. They complete a
diary in which they record the times they have intercourse and how they are feeling daily.
The diaries are submitted by mail each week or at the doctor's or midwife's visit until
delivery. The women have a pelvic exam and ultrasound and complete questionnaires about
problems during pregnancy, overall well-being, attitude toward induction of labor, physical
activity, body image during pregnancy, stress and social support, habits at home, and
environmental conditions, such as weather.
Risks of maternal and neonatal complications, even fetal death, increase with prolonged
gestation. Recent studies suggest that the risks may start to increase even before 40 weeks
of gestation, which challenges the current paradigm of induction after 41 weeks. Preliminary
findings seem to suggest that induction before 40 weeks may actually reduce the risk of
cesarean delivery. However, induction in women with an unripe cervix has a high risk of
failed induction and cesarean delivery. Cervical ripening at hospital prior to induction is
also associated with substantial costs and inconvenience to the woman.
Vaginal intercourse in late pregnancy has long been known to women to accelerate the onset of
labor. It is recommended by many physicians and nurses to prevent prolonged pregnancy.
However, scientific evidence to support this common practice is scarce and inconsistent. We
propose a prospective observational study to assess the effects of frequent intercourse on
the timing of delivery in term pregnancies.
A total of 510 nulliparous women with low risk pregnancies will be recruited during their
antenatal visit after 36 plus 6 and before 39 plus 0 weeks of gestation at the Naval Medical
Center San Diego. Subjects who have had infrequent intercourse (less than once per week)
during the last four weeks before their visit will be asked to abstain from intercourse for
the duration of pregnancy (or use condoms) (we expect to recruit 255 women in this subgroup).
Subjects having vaginal intercourse more than once per week during the last four weeks will
be asked to maintain or increase their frequency of intercourse up to three times a week (we
expect to recruit 255 women for this subgroup). Women will be asked to record physical
conditions and vaginal intercourse in a diary until delivery. An ultrasound will assess fetal
biometry and cervical length and volume. A pelvic exam will calculate Bishop Score. Obstetric
information will be extracted from medical records after birth. Time to delivery and rate of
cesarean delivery will be compared between the women without sex and women with frequent sex.
The effects of intercourse at term on time to delivery and cesarean delivery may have
important clinical implications.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02523755 -
Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
|
Phase 4 |